@Ruby15 i have observed these games and mentioned them on n off last year as "Invisible Hands", and ° Price fixers", but was told off as alarmists by "well meaning" contrrians and faultfinders.
Thanks to @Fathom beautiful illustrations a week ago, i feel vindicated; esp you could see blatant games played in last few days.
I agree, the long list of company-making achievwments by Gmed should have put Gmed MC in $150m to $200m range, 30c-40c.
(IMO Prizma, UsFDA+CE+TGA+TaiwanFDA Four (4) reg.approvals alone are worth U$100m-200m in a TO situation. plus Gmpatch/Vsms: CE + USFDA/Eua in covid19, another $100m-150m in TO, by IRTC, BEAT or Medtronic.
Total $200m to $300m)
As i hv repeatedly said, in HKEx, pre revenue (0, ZERO ,revenue) , if GMV IPOed today, MC will be A$300m to $600m. Manipulaters are well aware of these HKEX facts. ...so here we are at 6.7c, $45m MC
If you can't beat them, join them by accumulating more, and hold till Nasdaq or when sp reach your target.
U$880,000 usa govt cash injection/bonus will put us into Q3 nicely Cheers aimo
ps Ofc others will say $45m MC is what gmv deserve given low reveneues etc etc. They are entitled to their opinions.
